pSivida Corp. (NASDAQ:PSDV), a leader in developing sustained release, drug delivery products for treating eye diseases, announced that it has signed two funded …
pSivida Corp. (NASDAQ:PSDV), a leader in the development of sustained release, drug delivery products for treating eye diseases, announced financial results for its …
pSivida Corp. (NASDAQ:PSDV), a leader in the development of sustained release drug delivery products for treating eye diseases, announced that the Office for …
MLV’s healthcare analyst Arlinda Lee weighed in with her views on pSivida Corp. (NASDAQ:PSDV) following the news that the company has completed enrollment in the Phase 3 …
pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug delivery products for treating eye diseases, today announced the completion of the …
In a research report sent to investors today, MLV analyst Arlinda Lee reiterated a Buy rating on pSivida Corp (NASDAQ:PSDV) with a $6.50 …
(BUSINESS WIRE)– pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug delivery products for treating eye diseases, today announced …
(BUSINESS WIRE)– pSivida Corp. (NASDAQ:PSDV)(ASX:PVA), a leader in the development of sustained release drug delivery products for treating eye diseases, today announced that …
In a research report issued today, MLV analyst Arlinda Lee reiterated a Buy rating on pSivida Corp (NASDAQ:PSDV) with a $6.50 price target, …
(BUSINESS WIRE)– pSivida Corp. (NASDAQ:PSDV), a leader in the development of sustained release drug delivery products for treating eye diseases, today announced that …
